NCT02869295 2021-07-29
NKTR-214
Nektar Therapeutics
Phase 1/2 Completed
Clinical Trials
10 trialsNCT00002950 2020-08-17
Topotecan Plus Sargramostim in Treating Patients With Advanced Cancer
Yale University
Phase 1/2 Completed
NCT00311597 2017-03-14
Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors
Wake Forest University Health Sciences
Phase 1/2 Completed
NCT00004979 2014-01-06
Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00002482 2013-11-06
Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00091052 2013-03-26
Radiation Therapy and Sargramostim in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00086723 2012-06-11
In Vivo Angiostatin Generation Using Tissue Plasminogen Activator and Captopril in Treating Patients With Progressive Metastatic Cancer
Northwestern University
Phase 1/2 Completed
NCT00004030 2011-03-24
VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin
Georgetown University
Phase 1/2 Completed
NCT00004923 2009-08-25
Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors
Yale University
Phase 1/2 Completed
NCT00004063 2009-04-30
Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown